Global Assets Advisory LLC Takes $5.24 Million Position in Humana Inc. (NYSE:HUM)

Global Assets Advisory LLC acquired a new stake in shares of Humana Inc. (NYSE:HUM) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,112 shares of the insurance provider’s stock, valued at approximately $5,240,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HUM. Rakuten Securities Inc. bought a new position in shares of Humana during the 4th quarter valued at $25,000. Gradient Investments LLC boosted its position in Humana by 200.0% in the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 40 shares during the last quarter. Cetera Trust Company N.A bought a new stake in shares of Humana during the 4th quarter valued at about $28,000. Private Wealth Management Group LLC purchased a new stake in shares of Humana during the 4th quarter valued at about $32,000. Finally, Carolinas Wealth Consulting LLC lifted its stake in shares of Humana by 274.1% in the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after purchasing an additional 74 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Up 0.7 %

Shares of NYSE:HUM opened at $358.04 on Tuesday. The company has a market cap of $43.14 billion, a price-to-earnings ratio of 22.29, a PEG ratio of 2.08 and a beta of 0.52. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The company has a 50-day moving average price of $340.74 and a 200 day moving average price of $354.79. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same period in the prior year, the company posted $9.38 EPS. The firm’s revenue for the quarter was up 10.7% on a year-over-year basis. As a group, equities research analysts predict that Humana Inc. will post 16.07 earnings per share for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.54 annualized dividend and a dividend yield of 0.99%. Humana’s payout ratio is currently 22.04%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on HUM shares. Wells Fargo & Company reduced their target price on shares of Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Jefferies Financial Group decreased their target price on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a report on Monday, April 22nd. UBS Group cut their price target on Humana from $334.00 to $326.00 and set a “neutral” rating for the company in a report on Thursday, April 25th. The Goldman Sachs Group decreased their price objective on Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $360.00 target price on shares of Humana in a report on Wednesday, June 12th. Fourteen research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $410.47.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.